<DOC>
	<DOC>NCT00124839</DOC>
	<brief_summary>The purpose of this study is to investigate whether naltrexone reduces the intensity and duration of flashbacks and dissociative states in patients with borderline personality disorder.</brief_summary>
	<brief_title>Naltrexone in Borderline Personality Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>In and Outpatients:Borderline personality disorder according to the Diagnostic and Statistical Manual for Mental Disorders, 4.Edition (DSM IV) DES(Dissociative Experience Scale)score: &gt; or equal 18 according to amendment4 (former value according to amendment 2 was &gt; or equal 25). Urinary test of opiates negative No psychopharmacological treatment for two weeks prior to study (fluoxetine four weeks) No Lithium for two months Lifetime diagnosis of psychotic disorder Current major depressive disorder (MDD) Lifetime diagnosis opioid dependence or current opioid abuse (10 to 7 days prior to study) Comedication with opioid analgetics Known naltrexone intolerance Liver disease Pregnancy and lactation period Other severe medical or neurological diseases Simultaneous participation in another study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Dissociation</keyword>
	<keyword>Flashbacks</keyword>
	<keyword>Self-injurious behavior</keyword>
</DOC>